Currently, there are more than 75 antibody drug conjugates (ADCs) in various stages of pre-clinical and clinical development. The combination of a targeted antibody coupled with a cytotoxic small-molecule drug (via a flexible linker) makes for a lethal and specific oncologic drug product. However, an ADC is a heterogeneous cocktail of molecules with a range […]
The post Key Analytical Challenges for Antibody Drug Conjugates appeared first on Bitesize Bio.
No comments:
Post a Comment